Kumar P, Ahuja N, Bhatnagar R
Centre for Biotechnology, Jawaharlal Nehru University, New Delhi 110067, India.
Infect Immun. 2001 Oct;69(10):6532-6. doi: 10.1128/IAI.69.10.6532-6536.2001.
The structural gene for anthrax edema factor (EF) was expressed in Escherichia coli under the control of a powerful T5 promoter to yield the 89-kDa recombinant protein that reacted with anti-EF antibodies. Recombinant EF was purified to homogeneity by a two-step procedure involving metal chelate affinity chromatography and cation-exchange chromatography. From 1 liter of culture, 2.5 mg of biologically active EF was easily purified. This is the first report of purification of anthrax EF from E. coli. EF purified from E. coli was biologically and functionally as active as its Bacillus anthracis counterpart. The recombinant protein could compete with lethal factor for binding to protective antigen. Sequence analysis revealed a stretch of seven amino acids, Val Tyr Tyr Glu Ile Gly Lys, present both in EF (residues 136 to 142) and lethal factor (residues 147 to 153). To investigate the role of these seven residues in binding to protective antigen, the residues were individually mutated to alanine in EF. Mutations in residues Tyr137, Tyr138, Ile140, and Lys142 of EF specifically blocked its interaction with anthrax protective antigen. The adenylate cyclase activity of the mutants remained unaffected. The results suggested that residues Tyr137, Tyr138, Ile140, and Lys142 are required for binding of EF to anthrax protective antigen, which facilitates its entry into susceptible cells.
炭疽水肿因子(EF)的结构基因在强大的T5启动子控制下于大肠杆菌中表达,产生了与抗EF抗体发生反应的89 kDa重组蛋白。通过两步法,即金属螯合亲和色谱法和阳离子交换色谱法,将重组EF纯化至同质。从1升培养物中,很容易纯化出2.5毫克具有生物活性的EF。这是关于从大肠杆菌中纯化炭疽EF的首次报道。从大肠杆菌中纯化的EF在生物学和功能上与其炭疽芽孢杆菌对应物一样具有活性。该重组蛋白可与致死因子竞争与保护性抗原的结合。序列分析显示,EF(第136至142位残基)和致死因子(第147至153位残基)中均存在一段七个氨基酸的序列,即Val Tyr Tyr Glu Ile Gly Lys。为了研究这七个残基在与保护性抗原结合中的作用,将EF中的这些残基逐个突变为丙氨酸。EF的Tyr137、Tyr138、Ile140和Lys142残基的突变特异性地阻断了其与炭疽保护性抗原的相互作用。突变体的腺苷酸环化酶活性未受影响。结果表明,Tyr137、Tyr138、Ile140和Lys142残基是EF与炭疽保护性抗原结合所必需的,这有助于其进入易感细胞。